We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

October 11, 2019

Digital Health in Asia - Well, Shanghai and Tokyo.

Events
Martin Kelly
&
Chandana Fitzgerald

A good part of September was spent in Asia at our gatherings in Shanghai and Tokyo at JLabs and IBM respectively. Over the last 5 years, we have been hosting these events all around the globe but this was a first for HealthXL and we thoroughly enjoyed it while also learning lots of new things. 

A good part of September was spent in Asia at our gatherings in Shanghai and Tokyo at JLabs and IBM respectively. Over the last 5 years, we have been hosting these events all around the globe but this was our first time in these dynamic cities.  

We’re pretty optimistic you have heard about the large investment and commercial deals happening in China. You have also probably read about the scale of the opportunity. You may have also heard of the dearth of doctors and issues with access to healthcare for large rural populations. 

It is hard not to be both excited and overwhelmed by the sheer magnanimity of it all. 

A couple of things on the day really hit home. Feng Ge (CEO - Jiahui International Hospital) explained how his trojan horse strategy to digital transformation starts with building a new hospital and partnering with one of the leading US health systems (Partners/Harvard). While a Kaiser like ‘all-in-one’ model does not exist in China, his team have decided to create one! The logic is you need the best doctors to attract consumers.  In addition, you need a new facility/site if you want to create the ideal holistic model leveraging digital. So, you have to build a new epicenter, and branch out to all aspects of health and care-giving from the centre. 

Given the shortage of healthcare professionals in China, it seems obvious that AI has to play a new role in supporting the needs of a burgeoning market. Marco Huesch (CMO and Managing Director - Ping An) explained how they are approaching the opportunity that Asia presents. He gave us the lay of the land on the foundation and structure of Chinese healthcare, and of gaps and opportunities.


What we found most inspiring is the lack of legacy. Nobody was debating the definitions of digital health or digital therapeutics or deep learning but rather talking about how to transform the current model, improve access and make money. Quite a refreshing change and a well deserved dose of honesty for those of us gathered!

What ensued were two captivating panel discussions - one with local health tech entrepreneurs, and the second with healthcare leaders from China and abroad. The entrepreneurs focused their discussion on the current landscape of digital health offerings in China - from technology to regulation and adoption, by outlining their own milestones. There was consensus that with government and privately-driven interest & investment in technology, it is an exciting time to be an entrepreneur in China. 

The second discussion was aimed at comparing and contrasting the West with the East so we can be educated on the opportunities and challenges. While everybody (the group comprised of Amy Gu (Hemi Ventures) , Robert Garber (7Wire Ventures), Farhana Nakhooda (Health Catalyst) , Philip Huang, (Roche Diagnostics) and Tony Estrella (Frontiers Health) were excited at the prospect of shared learnings and shared goals however the crux of the matter is that the societies function so differently that one cannot bring any assumptions while investing or partnering in China.  They highlighted the need to invest some serious money since the valuations in China can give Silicon Valley a run for its money.


Shanghai Event Report

Tokyo was both similar and different. Both are mega cities but in very different ways. Shanghai bursts with energy, bedazzled buildings and light shows on steroids (thanks to Golden Week) while Tokyo is strangely orderly given a population of over 30 million.


Our meeting in Tokyo focused on two topics where Japan is seen as a leader. AI and Senior Care, balancing a respect for tradition with a passion for the future. We captured opinions from Motoo Kusakabe (Open City Institute), Norishige Morimot (IBM) , Terry Sweeney (Watson Health), Jim Joyce (Health Beacon). 

Overall, a couple of themes stood out. First, user-centric design is paramount, and great technology including AI should be invisible. Much like how Tokyo, as a city, is designed - everything is organized, clean, pristine. Complexity was hidden and the design champions function and elegance. These qualities seem innate to every individual, and permeates society.  Second, a recognition of the holistic nature of health and wellbeing, as highlighted in Motoo’s presentation. 





A third, unspoken theme at Tokyo, was the excitement of the Rugby World Cup. Ireland’s loss to Japan in one match that coincided with our meeting (incidentally, of course) did not sully any spirits thanks to the healthcare leaders who came together to learn and share. There were only winners at this one!

Tokyo Event Report


If you are interested in learning about these markets (APAC), reach out to us and we can talk! 



We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
AI in Healthcare
AI in Healthcare
AI in Healthcare
AI in Healthcare

Masterclass: AI-based diagnostics - learnings from a real-world use case

21st October @ 9:00AM GMT

In this masterclass, Zachary Tan (Advisor at CancerAid; Venture Creation Partner at Aegis Ventures; more info here) & Lisa Zhu (Research Fellow of the Center for Eye Research Australia) will walk us through the key learnings from their latest article in Scientific Reports (Nature) on real-world AI-based screening for diabetic retinopathy in Australia. This early-stage study is one of the first globally to describe the real-world implementation of AI in healthcare.

Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Digital Health in Mental Health: Commercialization Models

21st October @ 10:45AM EDT

Join us in this informal conversation where we will discuss the best commercialisation models for digital companies in the mental health space. Our 75 minute sessions are guaranteed to be filled with interesting debate and great conversation.

Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.